Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
There have been many stories since the November 5 election about potential health care changes in 2025. People are asking, “What can we expect as far as Affordable Care Act (ACA) changes and continuation of ACA subsidies?” “Will Pharmacy Benefit Managers (PBMs) face continuing scrutiny?” “Could we see a future national abortion ban from the ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the controversial drug middlemen as the agency’s first report released last summer.
One week before President-elect Donald Trump’s inauguration, the Biden administration is finalizing a rule that sets new standards for the individual market under the Affordable Care Act (ACA). First proposed in October, the rule protects consumers from having their coverage swapped unwittingly. Brokers and agents that violate this policy, and pose other “unacceptable” risks, can ...
The Biden administration within days is expected to select the next batch of drugs that will be subject to Medicare price negotiations — a process that this time could include Novo Nordisk's blockbusters Ozempic and Wegovy.
House Speaker Mike Johnson said Tuesday that cuts to Social Security and Medicare won't be part of the legislative package being worked out to fund President-elect Donald Trump's agenda.
Congress will discuss the future of ACA Marketplace subsidies in the coming months, but 2025 subsidy eligibility guidelines are locked in, and there’s still time to select a Marketplace plan for 2025.
Six years after he entered office vowing to be California’s “health care governor,” Democrat Gavin Newsom has steered tens of billions in public funding to safety net services for the state’s neediest residents while engineering rules to make health care more accessible and affordable.
Buried in the news from last month was an interesting nugget posted by Fierce Pharma: “Following a dinner at Trump’s Mar-a-Lago estate last week, Eli Lilly CEO David Ricks pointed to raising drug prices in other developed nations as a key strategy to reduce costs in the U.S.
Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer (PFE.N), opens new tab COVID-19 treatment Paxlovid, Bristol Myers Squibb’s (BMY.N), opens new tab cancer cell therapies and vaccines from France’s Sanofi (SASY.PA), opens new tab at the start of 2025, according to data analyzed by healthcare research firm 3 Axis Advisors. Nearly all of the drug ...
A number of different factors are putting stress on the finances of retired and pre-retiree Americans. According to a new report from the Society of Actuaries Research Institute, retirees are less likely to report being “better off than expected” in 2024 than in 2021. The study also shows that pre-retirees are more conscious of unplanned ...